Home › Borstkanker › Arizona › Scottsdale
Borstkanker klinische studies in Scottsdale, AZ
18 studies voor Borstkanker zoeken deelnemers op locaties in en rond Scottsdale (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
RekruterenFase 2
- Mayo Clinic, Scottsdale
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
RekruterenFase 3
- Mayo Clinic, Scottsdale
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
RekruterenFase 3
- Ironwood Cancer & Research Centers, Scottsdale
Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer
RekruterenFase 2
- Mayo Clinic in Arizona, Scottsdale
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Rekruteren
- Honor Health Research Institute, Scottsdale
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruterenFase 3
- Mayo Clinic, Scottsdale
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
RekruterenFase 1
- Mayo Clinic of Scottsdale, Scottsdale
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RekruterenFase 1
- HonorHealth, Scottsdale
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
RekruterenFase 2
- Mayo Clinic in Arizona, Scottsdale
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
RekruterenFase 1
- HonorHealth Research Institute, Scottsdale
Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer
RekruterenFase 2
- Mayo Clinic in Arizona, Scottsdale
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
RekruterenFase 3
- Mayo Clinic - Scottsdale, Scottsdale
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RekruterenFase 2
- Mayo Clinic - Scottsdale, Scottsdale
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekruterenFase 3
- Ironwood Cancer & Research Centers, Scottsdale
Cancer Genetic Testing in Ethnic Populations
Rekruteren
- Mayo Clinic in Arizona, Scottsdale
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekruterenFase 1
- HonorHealth Research Institute, Scottsdale
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
RekruterenFase 4
- Scottsdale Medical Imaging, LLC, Scottsdale
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Scottsdale
Borstkanker studies in andere steden
- New York City, NY136 studies
- Houston, TX126 studies
- Boston, MA112 studies
- Nashville, TN81 studies
- Los Angeles, CA73 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Queens, NY64 studies
- Durham, NC64 studies
- Chicago, IL59 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Andere studies in Scottsdale
- Kanker (alle vormen)18 studies
- Metastatische kanker17 studies
- Prostaatkanker17 studies
- Colorectale kanker16 studies
- Niet-kleincellige longkanker15 studies
- Aldermeesklierkanker13 studies
- Melanoom10 studies
- Colitis ulcerosa8 studies
- Longkanker8 studies
- Leverkanker (hepatocellulair carcinoom)7 studies
- Ziekte van Alzheimer7 studies
- Drievoudig negatieve borstkanker7 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.